对罗库的急性耐受性 - 一个案例报告
Jong Ho Kim1, Sang Joon Park1, Youngsuk Kwon1
1Department of Anesthesiology and Pain Medicine, Chuncheon Sacred Heart Hospital, College of Medicine, Hallym University, Chuncheon, Korea.
对神经肌肉阻断剂 (NMBA) 的急性耐受性可能出乎意料地发生. 麻醉师应该准备好在没有特定危险因素的患者中管理这种现象.
科学领域:
- 麻醉学 麻醉学
- 药理学 药理学是指药理学的学科.
背景情况:
- 神经肌肉阻断剂 (NMBA) 的增强剂可以引起与初始剂量相似的反应.
- 即使没有特定的病理生理变化,NMBA也可能引起类似的反应.
研究的目的:
- 调查疑似对神经肌肉阻断剂的急性耐受性病例.
- 强调识别和管理对NMBAs急性耐受性的重要性.
主要方法:
- 一名50岁的男性患者接受了初始剂量罗库 (40毫克) 麻醉.
- 由于作用的持续时间很短,两剂强剂被给予,导致急性耐受性的怀疑.
- 监测肌肉功能恢复和自发呼吸,并在术后给予苏加马德克斯.
主要成果:
- 患者在用了增强剂量的罗库后迅速恢复,这表明急性耐受性.
- 肌肉功能在0.75的四列车比率以上恢复,同时保持自发呼吸.
- 苏加马德克斯用于逆转任何残留的神经肌肉阻塞.
结论:
- 麻醉师应考虑在没有明显病史的患者中对NMBAs的急性耐受性.
- 应该制定一个管理计划,以有效地解决对NMBAs的急性耐受性.
更多相关视频
09:58A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
06:22Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
Published on: April 7, 2021
相关概念视频
Depolarizing Blockers: Pharmocokinetics
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Skeletal Muscle Relaxants: Therapeutic Uses
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
